Obesity, essential hypertension and renin–angiotensin system
Open Access
- 1 October 2007
- journal article
- review article
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 10 (10A), 1151-1155
- https://doi.org/10.1017/s136898000700064x
Abstract
Abdominal obesity is a risk factor for cardiovascular disease worldwide, and it is becoming a dramatic issue for national health systems. Overweight and obesity are highly associated with multiple comorbidities, elevated blood pressure values, dyslipidaemia, reduced insulin sensitivity and alterations of large and minor vessels.Activation of the renin–angiotensin system (RAS) in adipose tissue may represent an important link between obesity and hypertension. Angiotensin II has been shown to play a role in adipocyte growth and differentiation. Adipocytes also secrete adiponectin, enhancing insulin sensitivity and preventing atherosclerosis. Blockade of the RAS with either an angiotensin-converting enzyme inhibitor or an angiotensin II receptor blocker results in a substantial increase in adiponectin levels and improved insulin sensitivity. Obesity-related hypertension needs a comprehensive approach to treatment including both weight loss and pharmacological therapies. Antihypertensive drugs prescription should be based on guidelines recommendations for management of hypertension, taking into account the growing evidences about the relationship between some antihypertensive drugs and the development of new-onset diabetes.This review discusses the role of RAS in the relationship between obesity, essential hypertension and insulin resistance.This publication has 50 references indexed in Scilit:
- Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive SubjectsHypertension, 2006
- Are Obesity-Related Metabolic Risk Factors Modulated by the Degree of Insulin Resistance in Adolescents?Diabetes Care, 2006
- Weight Loss and the Renin-Angiotensin-Aldosterone SystemHypertension, 2005
- Obesity-Associated HypertensionHypertension, 2005
- Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?Hypertension, 2004
- Blood Pressure Control and Physician Management of Hypertension in Hospital Hypertension Units in SpainHypertension, 2004
- Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular HyperfiltrationHypertension, 2004
- Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential HypertensionHypertension, 2003
- The Kidney, Hypertension, and ObesityHypertension, 2003
- Lisinopril Versus Hydrochlorothiazide in Obese Hypertensive PatientsHypertension, 1997